In 2021, Winona sales in the chain pharmacy channel amounted to 490 million yuan ($67.2 million).
Recently, Ma Chunwei, the General Manager of the OTC Division of BTN, revealed the current data related to Winona’s offline OTC chain pharmacies in an interview with the media. This is the first time Winona has disclosed the development of its offline OTC chain pharmacy channel to the public.
According to Ma Chunwei, “Winona cooperates with chain pharmacies truly began in 2016. At that time, The market volume of Winona was around 500,000 yuan ($68,600). Last year, Winona sales in chain pharmacies surpassed 770 million yuan ($105.7 million).”
Ma Chunwei also stated that in 2021, Winona sales in the chain pharmacy channel amounted to 490 million yuan ($67.2 million). In 2022, Winona revenue in this channel experienced a year-on-year growth rate of 57.14%.
It is worth mentioning that, as disclosed, Winona currently cooperates with over 74,000 terminal OTC pharmacies offline, with over 550 partnering chain pharmacy brands covering 26 provinces. Among them, Winona sales in Jianzhijia and Jian Zhi Jia exceeded 200 million yuan ($27.4 million) and 110 million yuan ($15.1 million), respectively, in 2022.
It is reported that BTN initially collaborated with commercial companies and distributors for sales, and later expanded to include clients such as Yixintang, China National Pharmaceutical Group Corporation (Sinopharm), Jiuzhoutong, and Jianzhijia. Since 2016, they have been adjusting their online strategic deployment, increasing cooperation with commercial clients and direct suppliers, while also establishing expertise in the sensitive skin field through pharmacy sales. According to an internal source from BTN, their focus this year is on strengthening their offline channels, which includes OTC chain pharmacies.
